MYD88 and colitis: The effectiveness of similar polysaccharides like ASP-Ag-AP and GLP in reducing colitis via the TLR4/MyD88/NF-κB pathway suggests that EPS-LM, which also exerts anti-inflammatory effects through this pathway, may have comparable protective benefits against inflammatory conditions such as colitis.